Maintenance therapy in
advanced NSCLC
Encouraging approaches
Roger Y. Tsang, MD, FRCPC and Charles A. Butts, MD, FRCPC

The effects of androgen
deprivation on intimacy
Early interventions to minimize
emotional suffering
Lauren M. Walker, BA and John W. Robinson, PhD, RPsych Lauren M. Walker, BA and John W. Robinson, PhD, RPsych

Controlling nausea and
vomiting in patients
undergoing chemotherapy
Toward more effective clinical practice
David Warr, MD, FRCPC and Carlo DeAngelis, PharmD
Funded by an unrestricted grant from
Merck Frosst Canada Ltd.

Predictive oncology comes
to colorectal cancer
Report from the 2008 Eastern
Canadian Colorectal Cancer
Consensus Conference
Derek Jonker, MD, FRCPC et al

Five-year experience of McGill’s Adolescent and Young Adult Program
Challenges and successes
Michael Palumbo, MD, PhD, Petr Kavan, MD, PhD et al

Review of important clinical trials with
commentaries by Canadian experts
The 50th American Society of Hematology Annual Meeting
Tyrosine kinase inhibitors in early chronic phase CML
A. Robert Turner MD, FRCPC
Rituximab added to standard therapy in advanced CLL
Pentostatin replacing fludarabine in early CLL
Flavopiridol in relapsed CLL
Loree Larratt, MD, FRCPC

The growing role of private sector payment for cancer care
Kong Khoo, MD, FRCPC

Selected abstracts from the 2009 Annual Meeting of CAMO

Professional meetings roster
Your calendar dates for essential
conferences and symposia

New drugs and indications
A review of recent cancer therapy
approvals in Canada and the US